Dr. Majid T. Maybody, MD

Dr. Maybody practices at Active Life Health of NY in Smithtown, New York.

Dr. Maybody's NPI, 1083633267, was assigned on July 19, 2006. Dr. Maybody holds New York license 231711.

Dr. Maybody's primary practice is Active Life Health of NY, at 363 State Rte 111, Smithtown, NY 11787 in Suffolk County. The practice phone is (631) 656-8796.

Dr. Maybody's primary practice is Active Life Health of NY in Smithtown, New York. Dr. Maybody is also affiliated with Westchester Medical Center. The medical group on file is New York Cancer & Blood Specialists. Dmand AI also links Dr. Maybody to 4 more hospitals, 12 medical groups and 5 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Maybody practices, 10 sites in all. Vendor and product names are available with a free account.

Vascular and interventional radiology is Dr. Maybody's primary specialty in the NPI Registry, under taxonomy code 2085R0204X. Dmand AI has Dr. Maybody's licenses on file in 2 states: New York and New Mexico.

CMS data shows 1,164 Medicare services from Dr. Maybody across 23 procedure codes in 2024, for 687 Medicare patients. Medicare paid $561,346 for them.

CMS counts 687 Medicare patients who saw Dr. Maybody in 2024. The largest group is 65 to 74, with 240 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 29% are also on Medicaid. Their average risk score is 2.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Maybody's median patient age at 50, with 47% women.

In 2024, Dr. Maybody wrote 82 Medicare Part D claims for 66 patients. 89% of them were for generic drugs. CMS names the drug for 80 of them, across 1 drug with 11 or more claims each, at $57 in total drug cost. In 2023, CMS named 103 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Maybody for performance year 2024, reported as part of a group. Dr. Maybody accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 69 papers to Dr. Maybody, published from 2013 to 2023. 2016 was the busiest year, with 11. The most frequent topics are Tomography, X-Ray Computed, Embolization, Therapeutic and Image-Guided Biopsy. Dr. Maybody has published most often in J Vasc Interv Radiol. Dr. Maybody's most frequent co-authors are Stephen Barnett Solomon, MD, Joseph Patrick Erinjeri, MD, PhD and Jeremy Charles Durack, MD.

CMS Open Payments shows 12 general payments to Dr. Maybody from 5 drug and device companies from 2017 to 2024. Food and beverage make up the largest share, 100% of the total. Penumbra, Inc. paid the most, $225.